🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for HLA Antibodies

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity NCT07134491n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Piece of kidney removal, Stool collection, Blood collection HLA Antibodies in Systemic Lupus Erythematosus NCT06921239n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens Trifecta-Lung cfDNA-MMDx Study NCT05837663n/a19 sites📍 Phoenix📍 Gainesville📍 Jacksonville University of Alberta The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT NCT06362967Phase 21 site📍 Hefei Anhui Provincial Hospital · Tests: Immunoadsorption or plasma exchange combined with rituximab, high-dose IVIG Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET) NCT07607197Phase 1, Phase 21 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Autologous Hematopoietic Stem Cell Transplantation CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation NCT06774365n/a4 sites📍 Bari📍 Bologna📍 Milan IRCCS Azienda Ospedaliero-Universitaria di Bologna Trifecta-Kidney cfDNA-MMDx Study NCT04239703n/a31 sites📍 Tampa📍 Baltimore📍 Baltimore University of Alberta · Tests: MMDx, Prospera, HLA antibody Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-celiac Enteropathies NCT07070596n/a1 site📍 Terrassa Hospital Mutua de Terrassa Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas NCT05751798Phase 1, Phase 211 sites📍 Anderlecht📍 Edegem📍 Lyon OSE Immunotherapeutics · Tests: Part A: OSE-279 100mg, Part A: OSE-279 300mg, Part A: OSE-279 600mg, Part B: OSE-279 600 mg and OSE2101, Part C: OSE-27… Trifecta-Heart cfDNA-MMDx Study NCT04707872n/a12 sites📍 Little Rock📍 Tampa📍 West New York University of Alberta · Tests: MMDx diagnostic test, Prospera, HLA antibody A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer NCT06380816Phase 1, Phase 24 sites📍 London📍 Manchester📍 Newcastle upon Tyne Cancer Research UK · Tests: UCB4594
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy